Education Sessions
Delivering While Transforming: Advanced
Drug Delivery Systems
E-MG3
| 5 November 13.15-17.00 | Track: Manufacturing |
ISPE CEUs: 0.3
A partnership of pharmaceutical and medical device companies is evolving to bring several novel combination products. These innovative products enable the delivery of drugs locally versus systemically, maximizing dosage where needed while minimizing elsewhere. If your drug cannot be administered orally, there are now needle-free and non-invasive alternatives to “needles”. Several combination products have already been developed for targeted delivery in the areas of cancer, asthma and other respiratory disease, cardiovascular disease, diabetes, orthopedics, and vaccines. One of the inhaled insulin products is on the market and several others are in late stage development.
This session showcases potential benefits as well as challenges associated with several types of advanced drug delivery systems and provide the attendees with insight into the potential impact of the convergence of medical devices and therapeutic agents.
Hear presentations specific to new technologies such as:
- Metered dose inhalation system
- Microdevices for topical and intradermal delivery
- Organ-specific drug delivery systems
- Transcutaneous needle-free delivery systems
- Other novel drug delivery technologies
Take Back to Your Job
- New drug delivery technologies
- Understand the links between new product development and drug delivery
- Have perspective on the future of drug delivery systems and ways drug development and delivery technologies apply across the industry
Who Should Attend
- Process development groups, R&D groups, quality engineers (QE), mechanical engineers (ME), and manufacturing engineers.
Community of Practice: Process/Product Development (PPD)
Session Leader
- Igor Gonda, CEO and President, Aradigm Corp
Session Speakers
- Gary Cleary, President & CTO, Corium International, Inc.
- Jeff Silverman, VP Operations, Abraxis BioScience